Economic consequences for Medicaid of human immunodeficiency virus infection
- PMID: 10113503
- PMCID: PMC4195165
Economic consequences for Medicaid of human immunodeficiency virus infection
Abstract
Medicaid is currently a major source of financing for health care for those with acquired immunodeficiency syndrome (AIDS) and to a lesser extent, for those with other manifestations of human immunodeficiency virus (HIV) infection. It is likely to become even more important in the future. This article focuses on the structure of Medicaid in the context of the HIV epidemic, covering epidemiological issues, eligibility, service coverage and use, and reimbursement. A simple methodology for estimating HIV-related Medicaid costs under alternative assumptions about the future is also explained.
References
-
- Bacchetti P, Osmond D, Chaisson RE, et al. Survival patterns of the first 500 patients with AIDS in San Francisco. The Journal of Infectious Diseases. 1988 May;157(5):1044–1047. - PubMed
-
- Baily MA. Private Insurance and the HIV Epidemic. Washington, D.C.: The George Washington University; Jun, 1989. Cooperative Agreement No. 18-C-99141/3-01 to the George Washington University. Prepared for the Health Care Financing Administration.
-
- Baily MA, Bilheimer L, Wooldridge J, et al. The Economic Consequences of HIV Infection For the Medicaid and Medicare Programs: An Exploratory Study. Washington, D.C.: The George Washington University; Jun, 1989. Cooperative Agreement No. 18-C-99141/3-01. Prepared for the Health Care Financing Administration.
-
- Bilheimer L. Service Needs of Persons with AIDS. Washington, D.C.: Mathematica Policy Research; Feb. 1989a. Cooperative Agreement No. 18-C-99141/3-01. Prepared for the Health Care Financing Administration.
-
- Bilheimer L. AIDS cost modeling in the U.S.: a pragmatic approach. Health Policy. 1989b Apr.11(2):147–168. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical